These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 29759671)

  • 1. Yield and Pitfalls of Ajmaline Testing in the Evaluation of Unexplained Cardiac Arrest and Sudden Unexplained Death: Single-Center Experience With 482 Families.
    Tadros R; Nannenberg EA; Lieve KV; Škorić-Milosavljević D; Lahrouchi N; Lekanne Deprez RH; Vendrik J; Reckman YJ; Postema PG; Amin AS; Bezzina CR; Wilde AAM; Tan HL
    JACC Clin Electrophysiol; 2017 Dec; 3(12):1400-1408. PubMed ID: 29759671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Familial cardiological and targeted genetic evaluation: low yield in sudden unexplained death and high yield in unexplained cardiac arrest syndromes.
    Kumar S; Peters S; Thompson T; Morgan N; Maccicoca I; Trainer A; Zentner D; Kalman JM; Winship I; Vohra JK
    Heart Rhythm; 2013 Nov; 10(11):1653-60. PubMed ID: 23973953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual phenotypic transmission in Brugada syndrome.
    Hermida JS; Arnalsteen-Dassonvalle E; Kubala M; Mathiron A; Traulle S; Anbazhagan K; Hermida A; Rochette J
    Arch Cardiovasc Dis; 2013; 106(6-7):366-72. PubMed ID: 23810369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic ajmaline challenge in patients with long QT 3 syndrome caused by the most common mutation: a multicentre study.
    Hohmann S; Rudic B; Konrad T; Duncker D; König T; Tülümen E; Rostock T; Borggrefe M; Veltmann C
    Europace; 2017 Oct; 19(10):1723-1729. PubMed ID: 27915266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sudden cardiac death in families with premature cardiovascular disease.
    Bruikman C; de Ronde MWJ; Amin A; Levy S; Lof P; de Ruijter U; Hovingh K; Tan HL; Pinto-Sietsma SJ
    Heart; 2020 Feb; 106(3):228-232. PubMed ID: 31422358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myotonic dystrophy type 1 mimics and exacerbates Brugada phenotype induced by Nav1.5 sodium channel loss-of-function mutation.
    Pambrun T; Mercier A; Chatelier A; Patri S; Schott JJ; Le Scouarnec S; Chahine M; Degand B; Bois P
    Heart Rhythm; 2014 Aug; 11(8):1393-400. PubMed ID: 24768612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Diagnostic Yield of Brugada Syndrome After Sudden Death With Normal Autopsy.
    Papadakis M; Papatheodorou E; Mellor G; Raju H; Bastiaenen R; Wijeyeratne Y; Wasim S; Ensam B; Finocchiaro G; Gray B; Malhotra A; D'Silva A; Edwards N; Cole D; Attard V; Batchvarov VN; Tome-Esteban M; Homfray T; Sheppard MN; Sharma S; Behr ER
    J Am Coll Cardiol; 2018 Mar; 71(11):1204-1214. PubMed ID: 29544603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value of the sodium-channel blocker challenge in Brugada syndrome.
    Therasse D; Sacher F; Babuty D; Mabo P; Mansourati J; Kyndt F; Redon R; Schott JJ; Barc J; Probst V; Gourraud JB
    Int J Cardiol; 2017 Oct; 245():178-180. PubMed ID: 28784436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel
    Monasky MM; Micaglio E; Ciconte G; Rivolta I; Borrelli V; Ghiroldi A; D'Imperio S; Binda A; Melgari D; Benedetti S; Mitrovic P; Anastasia L; Mecarocci V; Ćalović Ž; Casari G; Pappone C
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33946750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of electrocardiographic parameters and ajmaline test in the diagnosis of Brugada syndrome caused by SCN5A mutations.
    Hong K; Brugada J; Oliva A; Berruezo-Sanchez A; Potenza D; Pollevick GD; Guerchicoff A; Matsuo K; Burashnikov E; Dumaine R; Towbin JA; Nesterenko V; Brugada P; Antzelevitch C; Brugada R
    Circulation; 2004 Nov; 110(19):3023-7. PubMed ID: 15520322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A balanced translocation disrupting SCN5A in a family with Brugada syndrome and sudden cardiac death.
    Yeates L; Ingles J; Gray B; Singarayar S; Sy RW; Semsarian C; Bagnall RD
    Heart Rhythm; 2019 Feb; 16(2):231-238. PubMed ID: 30170230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ventricular arrhythmia during ajmaline challenge for the Brugada syndrome.
    Dobbels B; De Cleen D; Ector J
    Europace; 2016 Oct; 18(10):1501-1506. PubMed ID: 26941343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Procainamide infusion in the evaluation of unexplained cardiac arrest: from the Cardiac Arrest Survivors with Preserved Ejection Fraction Registry (CASPER).
    Somani R; Krahn AD; Healey JS; Chauhan VS; Birnie DH; Champagne J; Sanatani S; Angaran P; Gow RM; Chakrabarti S; Gerull B; Yee R; Skanes AC; Gula LJ; Leong-Sit P; Klein GJ; Gollob MH; Talajic M; Gardner M; Simpson CS
    Heart Rhythm; 2014 Jun; 11(6):1047-54. PubMed ID: 24657429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac Abnormalities in First-Degree Relatives of Unexplained Cardiac Arrest Victims: A Report From the Cardiac Arrest Survivors With Preserved Ejection Fraction Registry.
    Steinberg C; Padfield GJ; Champagne J; Sanatani S; Angaran P; Andrade JG; Roberts JD; Healey JS; Chauhan VS; Birnie DH; Janzen M; Gerull B; Klein GJ; Leather R; Simpson CS; Seifer C; Talajic M; Gardner M; Krahn AD
    Circ Arrhythm Electrophysiol; 2016 Sep; 9(9):. PubMed ID: 27635072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac evaluation of pediatric relatives in sudden arrhythmic death syndrome: a 2-center experience.
    Wong LC; Roses-Noguer F; Till JA; Behr ER
    Circ Arrhythm Electrophysiol; 2014 Oct; 7(5):800-6. PubMed ID: 25194972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High prevalence of concealed Brugada syndrome in patients with atrioventricular nodal reentrant tachycardia.
    Hasdemir C; Payzin S; Kocabas U; Sahin H; Yildirim N; Alp A; Aydin M; Pfeiffer R; Burashnikov E; Wu Y; Antzelevitch C
    Heart Rhythm; 2015 Jul; 12(7):1584-94. PubMed ID: 25998140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignant response to ajmaline challenge in SCN5A mutation carriers: experience from a large familial study.
    Gandjbakhch E; Fressart V; Duthoit G; Marquié C; Deharo JC; Pousset F; Hebert JL; Simon F; Himbert C; Klug D; Charron P; Hidden-Lucet F
    Int J Cardiol; 2014 Mar; 172(1):256-8. PubMed ID: 24476701
    [No Abstract]   [Full Text] [Related]  

  • 18. The Utility of Sodium Channel Provocation in Unexplained Cardiac Arrest Survivors and Electrocardiographic Predictors of Ventricular Fibrillation Recurrence.
    Ensam B; Cheung CC; Almehmadi F; Gregers Winkel B; Scrocco C; Brennan P; Leong K; Muir A; Vanarva A; Tfelt-Hansen J; Roberts JD; Krahn AD; Behr ER
    Circ Arrhythm Electrophysiol; 2022 Dec; 15(12):e011263. PubMed ID: 36441561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SCN5A mutation type and topology are associated with the risk of ventricular arrhythmia by sodium channel blockers.
    Amin AS; Reckman YJ; Arbelo E; Spanjaart AM; Postema PG; Tadros R; Tanck MW; Van den Berg MP; Wilde AAM; Tan HL
    Int J Cardiol; 2018 Sep; 266():128-132. PubMed ID: 29709244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ajmaline Testing and the Brugada Syndrome.
    Rizzo A; Borio G; Sieira J; Van Dooren S; Overeinder I; Bala G; Pappaert G; Maj R; Osório TG; Terasawa M; Galli A; Cecchini F; Miraglia V; Ströker E; La Meir M; Brugada P; Chierchia GB; de Asmundis C
    Am J Cardiol; 2020 Nov; 135():91-98. PubMed ID: 32861732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.